entrotech life sciences, an organization focused on helping healthcare professionals save lives, announced the launch of its PrevahexCHX Antimicrobial Dressing, the first in a suite of PrevahexCHX products designed to help prevent catheter-related bloodstream infections (CRBSIs) and surgical site infections (SSIs).
PrevahexCHX antimicrobial dressings incorporate groundbreaking, advanced technology utilizing pure chlorhexidine (CHX) to provide rapid and broad-spectrum protection at wound and catheter sites. The dressing is manufactured through a revolutionary non-thermal, PCA-free process that ensures the rapid onset of action of pure chlorhexidine, as well as the breathability and visibility of the wound site. PrevahexCHX is the only antimicrobial dressing cleared by the FDA with pure chlorhexidine coverage throughout the transparent areas of the dressing.
“New evidence shows that catheter-related bloodstream infections and surgical site infections continue to cause unnecessary illness, healthcare costs, and deaths in hospitals across the U.S.,” says Jim McGuire, CEO of entrotech life sciences. “That’s why the entrotech life sciences team developed a groundbreaking product that unlocks the true potential of pure chlorhexidine alongside the innovative technology of a transparent, PCA-free film to advance our mission to prevent infection and create better patient outcomes.”
Chlorhexidine has long been utilized as a medical antimicrobial agent, with its pure form being most effective. Other chlorhexidine formulations contain additives such as gluconic acid and acetic acid that can potentially irritate the skin upon application. PrevavexCHX dressings are free of these additives, ensuring a comfortable patient and clinician experience.